Protective Effects of Lacticaseibacillus paracasei 63 on DSS-Induced Colitis in Mice
Open Access
Abstract
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon characterized by mucosal damage and immune dysregulation. This study aimed to evaluate the protective effects of Lacticaseibacillus paracasei 63 on ulcerative colitis. A dextran sulfate sodium (DSS)-induced male ICR mouse model of colitis was employed to assess the effects of oral administration of L. paracasei 63 on intestinal inflammation, barrier integrity, gut microbiota composition, short-chain fatty acid (SCFA) production, systemic inflammatory markers, and primary immune organ indices. Results showed that L. paracasei 63 significantly alleviated colitis and improved intestinal barrier function, accompanied by reduced TLR4 expression, decreased NF-κB p65 phosphorylation, and decreased MLCK-related markers. In addition, L. paracasei 63 administration modulated gut microbiota composition and increased SCFA levels, particularly acetate. These local intestinal changes were accompanied by reduced systemic inflammation, as evidenced by decreased serum IL-1β and TNF-α levels, along with an increased thymus index. Overall, L. paracasei 63 exerted significant ameliorative effects on DSS-induced ulcerative colitis, and these effects were associated with improvements in intestinal barrier integrity, inflammatory status, gut microbiota composition, SCFA production, and systemic immune-related indicators.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2022YFD2101503)
- Key Laboratory of Probiotics and Dairy Deep Processing of Yangzhou (YZ2020265)
This publication has 32 references indexed in Scilit:
- In vitro screening of synbiotics based on a four-strain probiotic blend and their therapeutic potential for ulcerative colitisBiomedicine & Pharmacotherapy, 2025
- Enhancing butyrate synthesis and intestinal epithelial energy supply through mixed probiotic intervention in dextran sulfate sodium-induced colitisFood Bioscience, 2024
- Targeting MLCK-MLC2 signaling pathway by tagatose alleviates dysregulated mitochondria-associated colonitisJournal of Functional Foods, 2024
- Lactobacillus paracasei Jlus66 relieves DSS-induced ulcerative colitis in a murine model by maintaining intestinal barrier integrity, inhibiting inflammation, and improving intestinal microbiota structureEuropean Journal of Nutrition, 2024
- Indole-3-Lactic Acid, a Tryptophan Metabolite of Lactiplantibacillus plantarum DPUL-S164, Improved Intestinal Barrier Damage by Activating AhR and Nrf2 Signaling PathwaysJournal of Agricultural and Food Chemistry, 2023
- Progress on the mechanisms of Lactobacillus plantarum to improve intestinal barrier function in ulcerative colitisThe Journal of Nutritional Biochemistry, 2023
- Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitisImmunity, Inflammation and Disease, 2023
- The impact of the gut microbiota on T cell ontogeny in the thymusCellular and Molecular Life Sciences, 2022
- COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis modelJournal of Molecular Medicine, 2018
- Role of serum cytokine profile in ulcerative colitis assessmentInflammatory Bowel Diseases, 2012